Search results for "Highlights"


 
Results 31 - 38 of about 38 for "Highlights".

Spotlight on esophageal adenocarcinoma

Although this study highlights a potential role of HPV status in the prognosis of esophageal adenocarcinoma, “ the use of HPV as a predictive marker for treatment remains unproven,” an accompanying commentary
August 2018

Endoscopic eradication therapy plus reflux control associated with decreased Barrett's recurrence rates

Standard reflux management protocol involved initial consultation that emphasized reflux control and proton-pump inhibitor (PPI) adherence, initiation or continuation of PPI therapy as described, medication reconciliation and assessment or
February 2017

Insufficient evidence to support gluten-free diet for IBS, meta-analysis finds

Included trials evaluated an exclusion diet versus an alternative or usual diet and assessed improvement in either global symptoms of irritable bowel syndrome (IBS) or abdominal pain.
August 2018

GI bleeding less common in U.S. veterans on NOACs than those on warfarin

Significant bleeding occurred in 2.5% of the patients on warfarin and 0.6% of the patients on non-vitamin K antagonist oral anticoagulants (NOACs).
March 2017

Pioglitazone associated with improved advanced fibrosis in patients with NASH

A recent meta-analysis looked at randomized clinical trials that examined the effect of thiazolidinediones on liver histology in patients with nonalcoholic steatohepatitis (NASH).
March 2017

Study finds substantial increase in HCV infection among younger women, children

Data from the National Notifiable Diseases Surveillance System and the Quest Diagnostics Health Trends database were used to estimate the incidence of hepatitis C virus (HCV) infection among women ages 15 to 44 years and children ages 2 to 13 years.
May 2017

Spotlight on nonalcoholic fatty liver disease and cardiac risk

Additionally, our results highlight the potential clinical utility of echocardiography for assessing NAFLD-related HF risk.
August 2017

Intensive fecal microbiota transplant may improve outcomes in active ulcerative colitis

Researchers at three Australian hospitals assigned patients with active ulcerative colitis to receive fecal microbiota transplant infusions from three to seven unrelated donors or placebo infusions.
February 2017

Result Page: Prev   1   2   3   4   Next